ArticleNeuro-oncology2025

Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity.

Shaoping Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.